Project Grant HT9425261E183
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Indiana University a $7.2 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, to conduct a five-year clinical research study investigating intra-articular injection of amobarbital to prevent post-traumatic osteoarthritis in patients sustaining severe ankle trauma. The research will be performed at Indiana University's Bloomington, Indiana campus and is expected to...
- Federal Grant Award Summary The Trustees of Indiana University received a $158,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on September 15, 2025, with an ultimate completion date of August 14, 2027. The grant supports the development of a genetically engineered mouse model of spinal ependymoma precursors in NF2-related schwannomatosis. This research will be conducted at Indiana University's Bloomington,...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of Miami's Office of Research Administration - School of Medicine Division a $602,841 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2026, with completion scheduled for June 14, 2030. The project, titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," focuses on advancing...
- Federal Grant Award Summary Indiana University received a $749,378 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2028. The award supports translational research investigating the systemic administration of STO-609 to prevent post-traumatic osteoarthritis using a porcine intraarticular fracture model. This research aims to develop medical interventions relevant to...
- Federal Grant Award Summary Indiana University received a $1.49M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 30, 2025, with completion scheduled for September 29, 2029. The award supports the Ovarian Cancer Academy, an initiative designed to advance ovarian cancer research through mentorship, networking, and collaborative activities. This four-year research effort will be conducted at Indiana...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine Division received a $1,092,670 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 15, 2026, with completion targeted for June 14, 2030. The project, titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," supports...
- Federal Grant Award Summary Northern California Institute For Research And Education, Inc. (NCIRE) received a $998,633 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2026 through August 31, 2029. The award funds research to identify and validate midlife risk factors and develop risk scoring models for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) among male and female...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $2.16M Project Grant on September 30, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on cerebellar neuromodulation to reduce cognitive dysfunction after multiple subconcussive impacts. The four-year project, scheduled for completion on September 29, 2029, will be performed at UCLA's Los Angeles campus through the Office of Research Administration. This award supports...
- Federal Grant Award Summary Asedasciences Inc. received a $1,050,320 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with an ultimate completion date of September 29, 2028. The awardee will develop a high-throughput cellular and biomimetic screening platform integrated with machine learning analytics and data visualization capabilities designed to assess neurotoxicity risk. This platform...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $2.41M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds research into cognitive rehabilitation interventions for the treatment of anger in veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Research activities will be conducted...